Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1347)
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,125
Price
$68.71
Total Value
$283.43K
Shares Held After
68,190
% of Holdings
5.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
72
Price
$32.85
Total Value
$2.37K
Shares Held After
28,836
% of Holdings
0.2%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
334
Price
$31.79
Total Value
$10.62K
Shares Held After
28,908
% of Holdings
1.1%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
4,222
Price
$31.28
Total Value
$132.08K
Shares Held After
29,242
% of Holdings
12.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
30
Price
$32.85
Total Value
$985.50
Shares Held After
10,276
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
139
Price
$31.79
Total Value
$4.42K
Shares Held After
10,306
% of Holdings
1.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,762
Price
$31.28
Total Value
$55.12K
Shares Held After
10,445
% of Holdings
14.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
37
Price
$32.85
Total Value
$1.22K
Shares Held After
10,172
% of Holdings
0.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
172
Price
$31.79
Total Value
$5.47K
Shares Held After
10,209
% of Holdings
1.7%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
2,173
Price
$31.28
Total Value
$67.98K
Shares Held After
10,381
% of Holdings
17.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
103
Price
$32.85
Total Value
$3.38K
Shares Held After
40,798
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
483
Price
$31.79
Total Value
$15.35K
Shares Held After
40,901
% of Holdings
1.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
6,100
Price
$31.28
Total Value
$190.83K
Shares Held After
41,384
% of Holdings
12.8%
Aldeyra Therapeutics, Inc. (ALDX)
Alfieri Michael — Principal Financial Officer
Shares
5,000
Price
$1.42
Total Value
$7.10K
Shares Held After
7,500
% of Holdings
66.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$539.99
Total Value
$86.40K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$537.66
Total Value
$21.51K
Shares Held After
40,673
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
419
Price
$531.71
Total Value
$222.79K
Shares Held After
40,713
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,739
Price
$530.94
Total Value
$1.45M
Shares Held After
41,132
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,558
Price
$530.09
Total Value
$1.36M
Shares Held After
43,871
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,064
Price
$529.05
Total Value
$562.91K
Shares Held After
46,429
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
732
Price
$527.93
Total Value
$386.44K
Shares Held After
47,493
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
871
Price
$526.95
Total Value
$458.97K
Shares Held After
48,225
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
546
Price
$525.99
Total Value
$287.19K
Shares Held After
49,096
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
331
Price
$525.08
Total Value
$173.80K
Shares Held After
49,642
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$522.88
Total Value
$20.92K
Shares Held After
49,973
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.18
Total Value
$251.21K
Shares Held After
494,920
% of Holdings
3.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
15,000
Price
$14.89
Total Value
$223.35K
Shares Held After
15,001
% of Holdings
100.0%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
1,930
Price
$62.07
Total Value
$119.80K
Shares Held After
78,185
% of Holdings
2.4%
CytomX Therapeutics, Inc. (CTMX)
Chu Yu-Waye — Chief Medical Officer
Shares
21,279
Price
$6.42
Total Value
$136.68K
Shares Held After
189,446
% of Holdings
10.1%
Revolution Medicines, Inc. (RVMD)
Wang Xiaolin — EVP, Clinical Development
Shares
2,010
Price
$99.48
Total Value
$199.96K
Shares Held After
116,063
% of Holdings
1.7%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
1,795
Price
$99.48
Total Value
$178.57K
Shares Held After
59,681
% of Holdings
2.9%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
2,753
Price
$99.48
Total Value
$273.87K
Shares Held After
125,512
% of Holdings
2.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
10,972
Price
$69.42
Total Value
$761.68K
Shares Held After
57,052
% of Holdings
16.1%
Revolution Medicines, Inc. (RVMD)
Wei Lin — Chief Medical Officer
Shares
2,073
Price
$99.48
Total Value
$206.22K
Shares Held After
101,366
% of Holdings
2.0%
Revolution Medicines, Inc. (RVMD)
Kelsey Stephen Michael — President, Research and Development
Shares
4,302
Price
$99.48
Total Value
$427.96K
Shares Held After
295,398
% of Holdings
1.4%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
12,871
Price
$99.48
Total Value
$1.28M
Shares Held After
276,698
% of Holdings
4.4%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
4,583
Price
$99.48
Total Value
$455.92K
Shares Held After
157,570
% of Holdings
2.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,111
Price
$69.42
Total Value
$146.55K
Shares Held After
47,635
% of Holdings
4.2%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
3,125
Price
$69.42
Total Value
$216.94K
Shares Held After
93,979
% of Holdings
3.2%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
375
Price
$69.42
Total Value
$26.03K
Shares Held After
24,077
% of Holdings
1.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,286
Price
$69.42
Total Value
$297.53K
Shares Held After
70,250
% of Holdings
5.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,029
Price
$69.42
Total Value
$279.69K
Shares Held After
43,273
% of Holdings
8.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,084
Price
$69.42
Total Value
$283.51K
Shares Held After
72,315
% of Holdings
5.3%
CytomX Therapeutics, Inc. (CTMX)
Ogden Christopher — Chief Financial Officer
Shares
19,323
Price
$6.42
Total Value
$124.11K
Shares Held After
296,948
% of Holdings
6.1%
CytomX Therapeutics, Inc. (CTMX)
McCarthy Sean A. — Director
Shares
118,969
Price
$6.42
Total Value
$764.14K
Shares Held After
1,078,922
% of Holdings
9.9%
CytomX Therapeutics, Inc. (CTMX)
BELVIN MARCIA — SVP, Chief Scientific Officer
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%
Showing 51–100 of 1347 transactions (page 2 of 27)